Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the tre...
Q1 2026
May 7, 2026
FY 2025
Feb 25, 2026
Q4 2025
Q3 2025
Nov 4, 2025
Q2 2025
Aug 6, 2025